<DOC>
	<DOCNO>NCT02381808</DOCNO>
	<brief_summary>To understand 286 gene mutation mutation rate ( include EGFR , HER2 , KRAS , BRAF , PIK3CA , ect ) deep sequence Chinese patient pulmonary adenocarcinoma relationship patient ' clinical feature ( include sex , age , smoke history adenocarcinoma subtype ) , specify predictive significance gene mutation new targeted therapy NSCLC patient , good understand molecular mechanism drug resistance EGFR-TKIs .</brief_summary>
	<brief_title>Study Potential Biomarkers Associated With Clinical Phenotype EGFR-TKIs No-small Cell Lung Cancer China</brief_title>
	<detailed_description>This study prospective identify biomarkers resistant afatinibï¼Œgefitinib erlotinib non-small cell lung cancer patient . Mutations whole exon 286 gene analyse deep sequence Chinese patient non-small cell lung cancer relationships patient ' clinical feature ( include sex , age , smoke history adenocarcinoma subtype ) , specify predictive significance gene mutation new targeted therapy NSCLC patient , good understand molecular mechanism drug resistance EGFR-TKIs .</detailed_description>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Age &gt; 18 year , male female Histologically confirm patient pulmonary adenocarcinoma ( Stage IIV ) ECOG 02 Patients enough paraffin tissue specimens fresh tissue detection Quality DNA extract tissue sample ensure DNA use DNA sequence FISH detection Subjects provide detailed clinical followup information Patients tumors Patients suffer serious disease like infectious disease ( viral hepatitis , HIV , etc ) Pregnant woman shall exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>